05B4 Jallo, Jack - Jefferson Medical College - Thomas Jefferson University
Jack Jallo, MD, PhD

Jack Jallo, MD, PhD

Contact Dr. Jallo

909 Walnut Street
Suite 200
Philadelphia, Pennsylvania 19107

(215) 955-7000
(215) 503-9170 fax

Most Recent Peer-reviewed Publications

  1. A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
  2. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)
  3. A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (duraseal dural sealant system) as a dural sealant in cranial surgery
  4. Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury
  5. Comments
  6. An analysis of phenytoin vs. levetiracetam for early seizure pharmacoprophylaxis following TBI
  7. Analysis of nonmodifiable risk factors for intracranial aneurysm rupture in a large, retrospective cohort.
  8. Comments
  9. Editorial comment
  10. Editorial comment
  11. Analysis of non-modifiable risk factors for intracranial aneurysm rupture in a large, retrospective cohort
  12. Comments
  13. Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury
  14. Editorial comment
  15. Comment
  16. Comments
  17. A murine model of hypertonic saline as a treatment for acute spinal cord injury: Effects on autonomic outcome - Laboratory investigation
  18. Editorial comment
  19. Comments
  20. The combination of selective inhibition of the cannabinoid CB1-, receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of Spinal Cord Injury
0